Retired Professor With Multiple System Atrophy Hopes for a Medically Assisted Death
mamamayerle / Pixabay

Retired Professor With Multiple System Atrophy Hopes for a Medically Assisted Death

According to a story from Southwest Journal, retired professor Karen Warren was first diagnosed in 2015 with multiple system atrophy, a lethal neurodegenerative disorder. The disease carries an unpleasant group…

Continue Reading Retired Professor With Multiple System Atrophy Hopes for a Medically Assisted Death

ICYMI: A Good Business Decision vs. The Right Ethical Choice: Conducting Clinical Trials

A recent article written by Craig Klugman debates the ethical obligations pharmaceutical companies have to conduct clinical trials for drugs which have a likely potential to benefit a patient population…

Continue Reading ICYMI: A Good Business Decision vs. The Right Ethical Choice: Conducting Clinical Trials
Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects
DarkoStojanovic / Pixabay

Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects

According to a publication from EurekAlert, a recent study helmed by the Royal Marsden NHS Foundation Trust suggests that female cancer patients tend to live slightly longer following treatment than…

Continue Reading Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects

Issues with Quality Assurance of Generic Drugs and How We Can Improve the Process

What are Generic Drugs? Generic drugs are any medications "equivalent" to brand name pharmaceuticals. These drugs are much cheaper than the brand name medications and the United States Food and…

Continue Reading Issues with Quality Assurance of Generic Drugs and How We Can Improve the Process
Duchenne Muscular Dystrophy and The Heart: Five Facts You Should Know
3dman_eu / Pixabay

Duchenne Muscular Dystrophy and The Heart: Five Facts You Should Know

According to a story from blog.cincinnatichildrens.org, a diagnosis of Duchenne muscular dystrophy is always an alarming piece of news; learning that your child has a progressive muscle atrophy disorder that…

Continue Reading Duchenne Muscular Dystrophy and The Heart: Five Facts You Should Know

LEGO to Introduce Braille Bricks for Children who are Blind! Coming to Stores in 2020

The Importance of Braille For any child with a rare disease that leads to blindness or visual impairment such as Stargardt disease, Usher Syndrome, Alström syndrome, or Retinal Blindness life…

Continue Reading LEGO to Introduce Braille Bricks for Children who are Blind! Coming to Stores in 2020
Researchers Find Gut Bacteria that Can Change Type A Blood to Type O
source: pixabay.com

Researchers Find Gut Bacteria that Can Change Type A Blood to Type O

Blood Donations For many people living with a rare disease such as Beta thalassemia, Hemophilia, Aplastic Anemia, Myelodysplastic syndromes, Acute Promyelocytic leukemia, and others, blood transfusions are not uncommon. For…

Continue Reading Researchers Find Gut Bacteria that Can Change Type A Blood to Type O
12-Year-Old with Idiopathic Thrombocytopenic Purpura Creates Nonprofit to Make Transfusions Easier for Kids
source: pixabay.com

12-Year-Old with Idiopathic Thrombocytopenic Purpura Creates Nonprofit to Make Transfusions Easier for Kids

Ella Casano is a 12-year-old living with Idiopathic Thrombocytopenic Purpura (ITP) who had a brilliant idea about how she could help other children living with rare diseases like her own.…

Continue Reading 12-Year-Old with Idiopathic Thrombocytopenic Purpura Creates Nonprofit to Make Transfusions Easier for Kids
Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy
WikiImages / Pixabay

Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy

According to a story from news-medical.net, an international research team affiliated with the UK Medical Research Council, Indiana University School of Medicine, and the University of Kansas have released a…

Continue Reading Research Highlights Distinctions Between Alzheimer’s Disease and Chronic Traumatic Encephalopathy

Experimental Hemophilia A Drug Loses Effectiveness Over Time, Efficacy Questionable After 8th Year

According to a publication from Reuters, based on early clinical data, American biotechnology company BioMarin Pharmaceuticals believes that a single injection of its experimental hemophilia A drug could relieve symptoms…

Continue Reading Experimental Hemophilia A Drug Loses Effectiveness Over Time, Efficacy Questionable After 8th Year
ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols
source: pixabay.com

ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols

According to a recent publication from BioPharma Dive, Dr. Janet Woodcock sat for an interview at the Biotechnology Innovation Organization's annual conference in Philadelphia earlier this month. Woodcock, the Director…

Continue Reading ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols

Legal and Ethical Questions: What is Pharma’s Obligation to Pursue Development of a Promising but Non-Profitable Drug?

  Dr. Craig Klugman, a bioethics professor at DePaul University, expresses his opinion in this recent article in Columbia University’s Bioethics.com. Dr. Klugman begins with a discussion of Pfizer’s biological drug,…

Continue Reading Legal and Ethical Questions: What is Pharma’s Obligation to Pursue Development of a Promising but Non-Profitable Drug?
Alnylam Pharmaceuticals Submits New Drug Application for Experimental Acute Hepatic Porphyria Drug
Aymanjed / Pixabay

Alnylam Pharmaceuticals Submits New Drug Application for Experimental Acute Hepatic Porphyria Drug

According to a press release from Alnylam Pharmaceuticals, the Massachusetts-based biopharmaceutical company has completed the submission of its New Drug Application (NDA) for givosiran — its experimental acute hepatic porphyria…

Continue Reading Alnylam Pharmaceuticals Submits New Drug Application for Experimental Acute Hepatic Porphyria Drug
4 out of 5 Functional Neurological Disorder Patients Have Lasting Neurological Symptoms
source: pixabay.com

4 out of 5 Functional Neurological Disorder Patients Have Lasting Neurological Symptoms

  Functional neurological disorder is a conversion disorder. This type of complex disorder is often thought to be linked with psychological symptoms, serious stress, or mental distress. With functional neurological…

Continue Reading 4 out of 5 Functional Neurological Disorder Patients Have Lasting Neurological Symptoms